サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：鎌状赤血球症治療市場：疾患別、治療法別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1335286

鎌状赤血球症治療市場：疾患別、治療法別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Sickle Cell Disease Treatment Market with COVID-19 Impact Analysis, By Disease, By Treatment, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
鎌状赤血球症治療市場：疾患別、治療法別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

鎌状赤血球症治療市場規模は2022年に10億1,070万米ドルとなり、2023年から2030年にかけてCAGR 30.8%で拡大

鎌状赤血球症治療市場-市場力学：

  • 新薬のイノベーションが市場成長を牽引
  • 鎌状赤血球症に対する20年ぶりの新規治療薬が英国で発見されました。ノバルティス社が製造するクリザンリズマブは、"革新的な治療法"と呼ばれています。BBCによると、クリザンリズマブは静脈に注射され、単独で使用することも、定期的な輸血や従来の医療と併用することもできます。ある研究では、クリザンリズマブを使用した患者が鎌状赤血球の危機を経験したのは年平均1.6回で、通常の年3回近くから減少しました。クリザンリズマブと呼ばれる薬剤は、16歳以上の鎌状赤血球貧血患者における血管閉塞性クリーゼの発生率を低下させるために使用されます。鎌状赤血球症治療市場は、このような画期的な治療法の発明により拡大しています。

鎌状赤血球症治療市場-セグメンテーション分析：

  • 世界の鎌状赤血球症治療市場は、疾患、治療法、地域によって区分されます。
  • 疾患に基づき、世界の鎌状赤血球疾患治療市場は鎌状赤血球貧血、鎌状ヘモグロビンc病、鎌状βサラセミア、その他にセグメント化されます。鎌状赤血球貧血セグメントは、予測期間中に最も高いCAGRで成長すると予想されます。この拡大は、遺伝子変異による鎌状赤血球貧血患者の増加の結果です。11番染色体に存在するヘモグロビン・ベータ遺伝子の変異が鎌状赤血球症を引き起こします。鎌状赤血球貧血の赤血球は、欠陥のあるヘモグロビンの結果、硬く、粘着性があり、奇形です。鎌状赤血球貧血の遺伝の有病率は、この市場の拡大を加速させています。
  • 治療法に基づき、世界市場は輸血、薬物療法、骨髄移植に区分されます。予測期間中、輸血分野が最大の市場シェアを占めると予想されます。鎌状赤血球症の治療における輸血の大量使用が、この上昇の原因です。急性胸部症候群（ACS）の治療には、単純輸血（ST）と自動赤血球交換（RCE）の両方が用いられます。鎌状赤血球症患者がよく罹患する脳卒中の治療における輸血の使用が増加していることが、この市場の拡大に拍車をかけています。

鎌状赤血球病治療市場-地理的洞察：

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。予測期間中、北米が市場を独占すると見られています。同地域の市場収益の伸びは、主に鎌状赤血球症の治療における大幅な進歩と、治療オプションへのアクセスの普及によってもたらされています。同地域の可処分所得の高さも市場収益拡大の主要因です。最も収益シェアが高いのは米国市場であり、これは政府援助の増加によるものです。さらに、現地の市場プレーヤーは、製品ラインナップを多様化し、世界のプレゼンスを確立するために、提携や買収を進めています。例えば、2022年、ファイザー社と世界・ブラッド・セラピューティクス社は、最終的に血液学製品ポートフォリオを増加させる取引に合意しました。

鎌状赤血球症治療市場-競合情勢：

市場に参入している主要企業は、Medunik USA、Bristol Myers Squibb Co.、Emmaus Medical Inc.、Addmedica、Novartis AG、Global Blood Therapeutics Inc.、Sanofi SA、Bluebird Biotechnology、Pfizer Inc.、Aruvant Sciences Inc.、Glycomimetics Inc.、Editas Medicine Inc.、CRISPR Therapeuticです。

目次

第1章 鎌状赤血球症治療市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 鎌状赤血球症治療の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 鎌状赤血球症治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 鎌状赤血球症治療市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 鎌状赤血球症治療市場情勢

  • 鎌状赤血球症治療市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 鎌状赤血球症治療市場- 疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • 鎌状赤血球貧血
    • 鎌状ヘモグロビンC病
    • 鎌状ベータサラセミア
    • その他

第8章 鎌状赤血球症治療市場- 治療別

  • 概要
    • 治療別セグメントシェア分析
    • 輸血
    • 薬物療法
    • 骨髄移植

第9章 鎌状赤血球症治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 鎌状赤血球症治療産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Medunik USA
    • Bristol Myers Squibb Co.
    • Emmaus Medical Inc.
    • Addmedica
    • Novartis AG
    • Global Blood Therapeutics Inc.
    • Sanofi SA
    • Bluebird Biotechnology
    • Pfizer Inc.
    • Aruvant Sciences Inc.
    • Glycomimetics Inc.
    • Editas Medicine Inc.
    • CRISPR Therapeutic

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sickle Cell Disease Treatment Market: Disease Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Sickle Cell Disease Treatment Market, by Disease 2018-2030 (USD Million)
  • TABLE Sickle Cell Disease Treatment Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Sickle Cell Disease Treatment Market, by Treatment 2018-2030 (USD Million)
  • TABLE Sickle Cell Disease Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sickle Cell Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE North America Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Europe Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE Europe Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE Latin America Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)

List of Figures

  • FIGURE Sickle Cell Disease Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Disease segment market share analysis, 2022 & 2030
  • FIGURE Disease segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Treatment segment market share analysis, 2022 & 2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Sickle Cell Disease Treatment Market share and leading players, 2022
  • FIGURE Europe Sickle Cell Disease Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Sickle Cell Disease Treatment Market share and leading players, 2022
  • FIGURE Latin America Sickle Cell Disease Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Sickle Cell Disease Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Sickle Cell Disease Treatment Market share analysis by country, 2022
  • FIGURE Germany Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Sickle Cell Disease Treatment Market share analysis by country, 2022
  • FIGURE India Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Sickle Cell Disease Treatment Market share analysis by country, 2022
  • FIGURE Brazil Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Sickle Cell Disease Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1577

REPORT HIGHLIGHT

Sickle Cell Disease Treatment Market size was valued at USD 1,010.7 Million in 2022, expanding at a CAGR of 30.8% from 2023 to 2030.

Hemoglobin, a protein that transports oxygen throughout the body, is impacted by sickle cell disease (SCD), a hereditary red blood cell (RBC) problem. Numerous consequences are brought on by it, including acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). Currently, doctors frequently recommend bone marrow and blood transplants to treat SCD. It entails removing the damaged bone marrow and replacing it with healthy bone marrow obtained from a donor. As they can lessen particular symptoms and extend patients' lives, other efficient therapies including pharmaceuticals and blood transfusions are also being used.

Sickle Cell Disease Treatment Market- Market Dynamics:

  • Innovation in novel medication drives the market growth.
  • The first new treatment for sickle cell disease in 20 years has been discovered in the United Kingdom. Crizanlizumab, a drug produced by Novartis, has been referred to be "an innovative treatment." According to the BBC, it is injected into a vein and can be used alone or in conjunction with regular blood transfusions and conventional medical care. In a study, patients using crizanlizumab experienced a sickle-cell crisis 1.6 times year on average, down from nearly three times annually in the norm. A drug called crizanlizumab is used to reduce the incidence of vaso-occlusive crises in sickle cell anemia patients aged 16 and older. The Sickle Cell Disease Treatment Market is expanding as a result of these inventive breakthrough treatments.

Sickle Cell Disease Treatment Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Sickle Cell Disease Treatment market is estimated to grow annually at a CAGR of around 30.8% over the forecast period (2023-2030)
  • The Sickle Cell Disease Treatment industry is projected to grow at a significant rate owing to the high incidence of sickle cell anemia disease
  • Based on the disease, the sickle cell anaemia segment is expected to grow at the highest CAGR over the forecast period
  • Based on the treatment, the blood transfusion segment is expected to capture the largest market share over the forecast period
  • Based on region, North America is expected to dominate the market over the forecast period

Sickle Cell Disease Treatment Market- Segmentation Analysis:

  • The Global Sickle Cell Disease Treatment Market is segmented based on disease, treatment, and Region.
  • Based on disease, the global Sickle Cell Disease Treatment market is segmented into sickle cell anaemia, sickle haemoglobin c disease, sickle beta thalassemia, others. The sickle cell anaemia segment is expected to grow at the highest CAGR over the forecast period. This expansion is the result of an increase in sickle cell anemia patients brought on by a gene mutation. A mutation in the haemoglobin-Beta gene found on chromosome 11 causes sickle cell disease. Red blood cells in sickle cell anemia are hard, sticky, and malformed as a result of the defective hemoglobin. The prevalence of inheriting sickle cell anemia is accelerating this market's expansion.
  • Based on treatment, the global market is segmented into blood transfusion, pharmacotherapy, bone marrow transplant. The blood transfusion segment is expected to capture the largest market share over the forecast period. The massive use of blood transfusion in the treatment of sickle cell disease is the cause of this rise. Acute chest syndrome (ACS) is treated with both simple transfusion (ST) of packed red blood cells and automated red cell exchange (RCE). The increasing use of blood transfusions in the treatment of stroke, which sickle cell disease patients commonly have, is fueling this market's expansion.

Sickle Cell Disease Treatment Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The region's market revenue growth is primarily being driven by significant advancements in the treatment of sickle cell disease and widespread accessibility to treatment options. The high level of disposable income in this region is also a major driver of the expansion of market revenue. The highest revenue share came from the U.S. market as a result of rising government assistance. Additionally, local market players are joining forces and making acquisitions to diversify their product offerings and establish a worldwide presence. For instance, in 2022, Pfizer Inc. and Global Blood Therapeutics, Inc. reached a deal that will ultimately increase the hematology product portfolio.

Sickle Cell Disease Treatment Market- Competitive Landscape:

The key players operating in the market are Medunik USA, Bristol Myers Squibb Co., Emmaus Medical Inc., Addmedica, Novartis AG, Global Blood Therapeutics Inc, Sanofi SA, Bluebird Biotechnology, Pfizer Inc., Aruvant Sciences Inc., Glycomimetics Inc., Editas Medicine Inc. and CRISPR Therapeutic.

Recent Developments:

In February 2022, Global Blood Therapeutics Inc. was granted permission to sell Oxbryta for the treatment of sickle cell disease (SCD)-related hemolytic anemia in adults and children 12 years of age and older as a monotherapy or in combination with hydroxycarbamide.

Key features of the study:

  • This proposed research study on Sickle Cell Disease Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Sickle Cell Disease Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Sickle Cell Disease Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Sickle Cell Disease Treatment market
  • Impact of COVID-19 on Sickle Cell Disease Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Sickle Cell Disease Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Sickle Cell Disease Treatment market, we have also included competitive landscape and key innovator analysis for the Sickle Cell Disease Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Sickle Cell Disease Treatment market.
  • In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Sickle Cell Disease Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SICKLE CELL DISEASE TREATMENT MARKET KEY PLAYERS

  • Medunik USA
  • Bristol Myers Squibb Co.
  • Emmaus Medical Inc.
  • Addmedica
  • Novartis AG
  • Global Blood Therapeutics Inc.
  • Sanofi SA
  • Bluebird Biotechnology
  • Pfizer Inc.
  • Aruvant Sciences Inc.
  • Glycomimetics Inc.
  • Editas Medicine Inc.
  • CRISPR Therapeutic

GLOBAL SICKLE CELL DISEASE TREATMENT MARKET, BY DISEASE

  • Sickle Cell Anaemia
  • Sickle Haemoglobin C Disease
  • Sickle Beta Thalassemia
  • Others

GLOBAL SICKLE CELL DISEASE TREATMENT MARKET, BY TREATMENT

  • Blood Transfusion
  • Pharmacotherapy
  • Bone Marrow Transplant

GLOBAL SICKLE CELL DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sickle Cell Disease Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sickle Cell Disease Treatment Market Snippet by Disease
    • 2.1.2. Sickle Cell Disease Treatment Market Snippet by Treatment
    • 2.1.3. Sickle Cell Disease Treatment Market Snippet by Country
    • 2.1.4. Sickle Cell Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Sickle Cell Disease Treatment Key Market Trends

  • 3.1. Sickle Cell Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sickle Cell Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sickle Cell Disease Treatment Market Opportunities
  • 3.4. Sickle Cell Disease Treatment Market Future Trends

4. Sickle Cell Disease Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sickle Cell Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sickle Cell Disease Treatment Market Landscape

  • 6.1. Sickle Cell Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sickle Cell Disease Treatment Market - By Disease

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease, 2022 & 2030 (%)
    • 7.1.2. Sickle Cell Anaemia
    • 7.1.3. Sickle Haemoglobin C Disease
    • 7.1.4. Sickle Beta Thalassemia
    • 7.1.5. Others

8. Sickle Cell Disease Treatment Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
    • 8.1.2. Blood Transfusion
    • 8.1.3. Pharmacotherapy
    • 8.1.4. Bone Marrow Transplant

9. Sickle Cell Disease Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Sickle Cell Disease Treatment Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Sickle Cell Disease Treatment Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Sickle Cell Disease Treatment Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Sickle Cell Disease Treatment Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Sickle Cell Disease Treatment Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Sickle Cell Disease Treatment Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Medunik USA
    • 10.2.2. Bristol Myers Squibb Co.
    • 10.2.3. Emmaus Medical Inc.
    • 10.2.4. Addmedica
    • 10.2.5. Novartis AG
    • 10.2.6. Global Blood Therapeutics Inc.
    • 10.2.7. Sanofi SA
    • 10.2.8. Bluebird Biotechnology
    • 10.2.9. Pfizer Inc.
    • 10.2.10. Aruvant Sciences Inc.
    • 10.2.11. Glycomimetics Inc.
    • 10.2.12. Editas Medicine Inc.
    • 10.2.13. CRISPR Therapeutic

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us